Clostridium difficile infection overview

Revision as of 17:04, 24 April 2015 by YazanDaaboul (talk | contribs)
Jump to navigation Jump to search
Resident
Survival
Guide

C. difficile Infection Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Classification

Differentiating Clostridium difficile infectionfrom other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Abdominal X Ray

Abdominal CT Scan

Other Imaging Findings

Biopsy

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Clostridium difficile infection overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Clostridium difficile infection overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Clostridium difficile infection overview

CDC on Clostridium difficile infection overview

Clostridium difficile infection overview in the news

Blogs on Clostridium difficile infection overview

Directions to Hospitals Treating Clostridium difficile

Risk calculators and risk factors for Clostridium difficile infection overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yazan Daaboul, M.D.

Overview

Clostridium difficile or CDF/cdf' is a species of bacteria of the genus Clostridium which are Gram-positive, anaerobic, spore-forming rods (bacillus).[1] Clostridium difficile (C. diff) is one of the most common hospital-acquired infections, particularly in elderly hospitalized patients, and also one of the most common complications of antibiotics in hospitalized patients. Patients are rarely infected unless the normal flora of the intestinal tract has been altered by antibiotics. Up to 10% of patients hospitalized >2 days are affected.Of note, most antibiotic-associated diarrhea is not due to C. diff, but is due to an osmotic type diarrhea. The antibiotics wipe out the gastrointestinal (GI) tract’s normal flora, which usually break down unabsorbed carbohydrates. These unabsorbed carbohydrates remain in the lumen and carry with them water, resulting in diarrhea.C. difficile is the most significant cause of pseudomembranous colitis,[2] a severe infection of the colon, often after normal gut flora is eradicated by the use of antibiotics.

Diagnosis

Symptoms

In adults, a clinical prediction rule found the best signs are[3] significant diarrhea ("new onset of > 3 partially formed or watery stools per 24 hour period"), exposure of antibiotics, abdominal pain, foul stool odor.

The presence of any one of these findings has a sensitivity of 86% and a specificity of 45%.[3] In a study on hospitalized patients with a prevalence of positive cytotoxin assays of 14%, the positive predictive value was 20% and the negative predictive value was 95%.

Treatment

Medical Therapy

Many persons will also be asymptomatic and colonized with Clostridium difficile. Treatment in asymptomatic patients is controversial, also leading into the debate of clinical surveillance and how it intersects with public health policy.

It is possible that mild cases do not need treatment.[4]

Patients should be treated as soon as possible when the diagnosis of Clostridium difficile colitis (CDC) is made to avoid frank sepsis or bowel perforation. Treatment is by stopping any antibiotics and commencing specific anticlostridial antibiotics, e.g. metronidazole.

References

  1. Ryan KJ; Ray CG (editors) (2004). Sherris Medical Microbiology (4th ed. ed.). McGraw Hill. pp. pp. 322-4. ISBN 0-8385-8529-9.
  2. "Pseudomembranous Colitis". eMedicine. WebMD. 1 July 2005. Retrieved 2007-01-11.
  3. 3.0 3.1 Katz DA, Lynch ME, Littenberg B (1996). "Clinical prediction rules to optimize cytotoxin testing for Clostridium difficile in hospitalized patients with diarrhea". Am. J. Med. 100 (5): 487–95. doi:10.1016/S0002-9343(95)00016-X. PMID 8644759.
  4. Nelson R. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD004610. PMID 17636768


Template:WH Template:WS